Literature DB >> 9445371

Effect of long-term treatment of 3T3-L1 adipocytes with chlorate on the synthesis, glycosylation, intracellular transport and secretion of lipoprotein lipase.

H Masuno1, K Sakayama, H Okuda.   

Abstract

Lipoprotein lipase (LPL) is synthesized and glycosylated in the endoplasmic reticulum (ER), transported through the Golgi to the cell surface, and finally secreted. To examine the role of heparan sulphate proteoglycans (HSPG) in the synthesis, activity, intracellular transport and secretion of LPL, 3T3-L1 adipocytes were cultured for 7 days in the presence of 20 mM chlorate, an inhibitor of sulphation of HSPG. Treatment of cells with 20 mM chlorate for 7 days caused a 55% decrease in LPL activity in the intracellular compartment and a 79% decrease in the cell-surface compartment. The synthetic rate of LPL in chlorate-treated cells was identical with that in control cells as determined by biosynthetic labelling. The study with endoglycosidase H (endo H) showed that the treatment with chlorate increased the proportion of LPL subunits which were totally endo H-sensitive. The study with a heparin-Sepharose column showed that 3T3-L1 adipocytes contained three forms of LPL. The first form, accounting for 35% of the LPL, did not bind to the heparin-Sepharose column and had little or no activity; the second form, accounting for 32%, bound to the column and was eluted with 0.4-0.75 M NaCl but had no activity; the third form, accounting for 33%, bound to the column and was eluted with 0.8-1.2 M NaCl and had activity. In chlorate-treated cells, the first form accounted for 66% of the LPL, the second form 15% and the third form 19%. When cells were incubated for 1 h with brefeldin A, which translocates Golgi proteins to the ER [J. Lippincott-Schwartz, L.C. Yuan, J.S. Banifacino and R.D. Klausner (1989) Cell 56, 801-813; J. Lippincott-Schwartz, J. Glickman, J.E. Donaldson, J. Robbins, T.E. Kreis, K.B. Seamon, M.P. Sheetz and R.D. Klausner (1991) J. Cell Biol. 112, 567-577], the chlorate-induced decrease in cellular LPL activity was restored. These findings indicate that LPL synthesized in chlorate-treated cells can be processed to be fully active, but chlorate-treated cells are unable to transport LPL to the Golgi and accumulate inactive LPL with a lower affinity for heparin in the ER. The treatment with chlorate decreased the proportion of LPL subunits that were endo H-resistant, indicating that the processing of oligosaccharide chains of LPL in the trans-Golgi was impaired in chlorate-treated cells. The amount of 35S-labelled LPL secreted by chlorate-treated cells was identical with that secreted by control cells, whereas the level of LPL activity in the medium of chlorate-treated cells was 25% of that in the medium of control cells, indicating that most of the LPL secreted by chlorate-treated cells was inactive.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445371      PMCID: PMC1219065          DOI: 10.1042/bj3290461

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes.

Authors:  Y Misumi; Y Misumi; K Miki; A Takatsuki; G Tamura; Y Ikehara
Journal:  J Biol Chem       Date:  1986-08-25       Impact factor: 5.157

2.  Chlorate: a reversible inhibitor of proteoglycan sulfation.

Authors:  D E Humphries; J E Silbert
Journal:  Biochem Biophys Res Commun       Date:  1988-07-15       Impact factor: 3.575

3.  Fate of lipoprotein lipase taken up by the rat liver. Evidence for a conformational change with loss of catalytic activity.

Authors:  T Chajek-Shaul; G Friedman; E Ziv; H Bar-On; G Bengtsson-Olivecrona
Journal:  Biochim Biophys Acta       Date:  1988-11-25

4.  Studies on inactivation of lipoprotein lipase: role of the dimer to monomer dissociation.

Authors:  J C Osborne; G Bengtsson-Olivecrona; N S Lee; T Olivecrona
Journal:  Biochemistry       Date:  1985-09-24       Impact factor: 3.162

5.  Chlorate--a potent inhibitor of protein sulfation in intact cells.

Authors:  P A Baeuerle; W B Huttner
Journal:  Biochem Biophys Res Commun       Date:  1986-12-15       Impact factor: 3.575

6.  Castanospermine inhibits glucosidase I and glycoprotein secretion in human hepatoma cells.

Authors:  V W Sasak; J M Ordovas; A D Elbein; R W Berninger
Journal:  Biochem J       Date:  1985-12-15       Impact factor: 3.857

7.  Influence of monensin on biosynthesis, processing and secretion of proteodermatan sulfate by skin fibroblasts.

Authors:  W Hoppe; J Glössl; H Kresse
Journal:  Eur J Biochem       Date:  1985-10-01

8.  Synthesis and secretion of lipoprotein lipase in 3T3-L1 adipocytes. Demonstration of inactive forms of lipase in cells.

Authors:  T Olivecrona; S S Chernick; G Bengtsson-Olivecrona; M Garrison; R O Scow
Journal:  J Biol Chem       Date:  1987-08-05       Impact factor: 5.157

9.  Maturation and secretion of lipoprotein lipase in cultured adipose cells. I. Intracellular activation of the enzyme.

Authors:  C Vannier; E Z Amri; J Etienne; R Négrel; G Ailhaud
Journal:  J Biol Chem       Date:  1985-04-10       Impact factor: 5.157

10.  Lipoprotein lipase: size of the functional unit determined by radiation inactivation.

Authors:  A S Garfinkel; E S Kempner; O Ben-Zeev; J Nikazy; S J James; M C Schotz
Journal:  J Lipid Res       Date:  1983-06       Impact factor: 5.922

View more
  1 in total

1.  Expression of human hepatic lipase negatively impacts apolipoprotein A-I production in primary hepatocytes from Lipc-null mice.

Authors:  Michelle Bamji-Mirza; Wandong Zhang; Zemin Yao
Journal:  J Biomed Res       Date:  2014-03-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.